Evaluation of a Peer Coach-Led Intervention to Improve Pain Symptoms (ECLIPSE)

July 19, 2023 updated by: VA Office of Research and Development

Evaluation of a Peer Coach-Led Intervention to Improve Pain Symptoms (ECLIPSE)

To maximize implementation potential of pain self-management in the VA, alternative delivery methods are needed to provide Veterans with education and support needed to self-manage their pain, without requiring additional resources from healthcare teams. A novel and promising approach is a peer coaching model, in which Veterans with chronic pain who are successfully managing their pain offer information, support, and mentorship to other Veterans with pain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The investigators' goal is to test the effectiveness of a peer coaching model among Veterans. The investigators are examining feasibility for implementation alongside effectiveness, to shorten the timeline to implementation.

Aim 1 (primary aim): To compare 6-month (primary endpoint) and 9-month (sustained effects) effects of peer-supported chronic pain self-management versus controls on overall pain (intensity and function).

Hypothesis 1: Veterans in the peer support arm will experience reduced overall pain compared to controls.

Aim 2 (secondary aim): To compare 6- and 9-month effects of peer-supported chronic pain self-management versus controls on self-efficacy, social support, pain coping, patient activation, health-related quality of life, and health service utilization.

Hypothesis 2: Veterans in the peer support arm will experience greater self-efficacy, social support, pain coping, patient activation, and health-related quality of life, and lower health service utilization, compared to controls.

Aim 3 (pre-implementation aim): To explore facilitators and barriers to implementation of peer support for chronic pain, intervention costs, and fidelity to the model.

Study Type

Interventional

Enrollment (Actual)

215

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Indianapolis, Indiana, United States, 46202-2884
        • Richard L. Roudebush VA Medical Center, Indianapolis, IN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • have musculoskeletal pain in the low back, cervical spine, or extremities (hip, knee, or shoulder) for 3 months
  • have at least moderate pain severity, defined by pain 5 on a 0 (no pain) to 10 (worst pain imaginable) scale
  • indicate willingness to engage in phone or in-person contact on a regular basis with another Veteran

Exclusion Criteria:

  • if the electronic medical record indicates a diagnosis of a psychotic disorder (e.g., International Classification of Diseases (ICD) ICD-9 codes 295-295.9 for schizophrenia)
  • current substance dependence (e.g., ICD-9 codes 304-304.9)
  • severe medical conditions precluding participation (e.g., New York Heart Association Class III or IV heart failure, ICD-9 codes 428-428.9 )
  • if the eligibility screener given to prospective participants reveals active suicidal ideation severe hearing or speech impairment
  • pending surgery for a musculoskeletal condition (e.g., back surgery)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Peer Coach Assignment
Veteran participants will be assigned to a peer coach, who delivered self-management instruction one-on-one over a 6-month period.
Veterans will be assigned a peer coach to meet with for 6 months to discuss pain self-management.
No Intervention: Control
Veteran participants will attend a 2-hour class in pain "basics" and pain self-management. Veterans will aso be given a set of pamphlets related to pain self-management.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brief Pain Inventory (BPI) (Overall Pain Assessment)
Time Frame: 6 months
The BPI was developed to assess the severity of pain and the impact of pain on daily functioning, and has been validated in primary care studies. (Range = 0-10, 0 = no pain, 10 = worst pain imaginable)
6 months
Brief Pain Inventory (BPI) (Overall Pain Assessment)
Time Frame: 9 months
The BPI was developed to assess the severity of pain and the impact of pain on daily functioning, and has been validated in primary care studies. (Range = 0-10, 0 = no pain, 10 = worst pain imaginable)
9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Catastrophizing
Time Frame: 6 months
Pain Catastrophizing Scale, a 13-item scale that assesses catastrophizing - a pain belief that has been found to be a strong predictor of poor treatment response. (Range: 0-52, higher numbers = higher catastrophizing)
6 months
Perceived Social Support
Time Frame: 6 months
Measures perceptions of social support.(Range: 12-84, higher numbers = higher perceptions of social support)
6 months
Perceived Social Support
Time Frame: 9 months
Measures perceptions of social support.(Range: 12-84, higher numbers = higher perceptions of social support)
9 months
Self Efficacy
Time Frame: 6 months
Adapted from the Arthritis Self Efficacy Scale (Range 0-10, higher numbers = higher self efficacy)
6 months
Self Efficacy
Time Frame: 9 months
Adapted from the Arthritis Self Efficacy Scale (Range 0-10, higher numbers = higher self efficacy)
9 months
Anxiety
Time Frame: 6 months
GAD-7 (Range 0-21, higher numbers = higher anxiety)
6 months
Anxiety
Time Frame: 9 months
GAD-7 (Range 0-21, higher numbers = higher anxiety)
9 months
Depression
Time Frame: 6 months
PHQ-8 (Range: 0-24, higher numbers = higher depression)
6 months
Depression
Time Frame: 9 months
PHQ-8 (Range: 0-24, higher numbers = higher depression)
9 months
Pain Catastrophizing
Time Frame: 9 months
Pain Catastrophizing Scale, a 13-item scale that assesses catastrophizing - a pain belief that has been found to be a strong predictor of poor treatment response. (Range: 0-52, higher numbers = higher catastrophizing)
9 months
Patient Activation
Time Frame: 6 months
Patient Activation Measure (Range: 0-100, higher numbers = higher activation)
6 months
Patient Activation
Time Frame: 9 months
Patient Activation Measure (Range: 0-100, higher numbers = higher activation)
9 months
General Health Perceptions
Time Frame: 6 months
SF-36 General Health Perceptions (Range: 0-100, higher numbers = higher health perceptions)
6 months
General Health Perceptions
Time Frame: 9 months
SF-36 General Health Perceptions (Range: 0-100, higher numbers = higher health perceptions)
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marianne Sassi Matthias, PhD MS BA, Richard L. Roudebush VA Medical Center, Indianapolis, IN

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2015

Primary Completion (Actual)

August 1, 2019

Study Completion (Actual)

August 1, 2019

Study Registration Dates

First Submitted

February 23, 2015

First Submitted That Met QC Criteria

February 27, 2015

First Posted (Estimated)

March 5, 2015

Study Record Updates

Last Update Posted (Actual)

July 27, 2023

Last Update Submitted That Met QC Criteria

July 19, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IIR 14-070
  • 1410626162 (Other Identifier: Indiana University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Upon request, the Research Service will consider requests for the final data sets underlying the publications to be provided to the public. The limited dataset will include de-identified data relevant to the specific request. Independent research groups can view relevant data to evaluate the extent that data sources support conclusions made by authors in published studies as well as observe additional emergent themes and view supplemental details that might not be included in publications.

IPD Sharing Time Frame

The data will become available once the study team completes all analyses.

IPD Sharing Access Criteria

The Research Service will evaluate individual requests.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Peer Coach Assignment

Subscribe